XASX
WQG
Market cap321mUSD
Oct 09, Last price
2.02AUD
1D
-0.49%
1Q
-0.98%
IPO
85.32%
Name
WCM Global Growth Ltd
Chart & performance
P/E
6.89
P/S
4.50
EPS
0.29
Div yield, %
4.81%
Shrs. gr., 5y
4.66%
Rev. gr., 5y
6.83%
Revenues
102m
-5.18%
Net income
67m
-4.04%
CFO
-48m
L-13.13%
Dividend
Sep 14, 20260.0235 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Contango Asset Management Limited functions as a publicly listed investment management firm. It caters to institutional investors by managing a diverse range of mandates, encompassing strategies focused on large-cap, mid-cap, small-cap, micro-cap, and income-generating assets. The company, which adopted its current name in August 2016, having previously been known as Tyrian Diagnostics Limited, maintains its headquarters in Sydney, Australia.
Key people
Valentina Stojanovska Cal
Independent Non-Executive Chairman of the Board · since 2017
Mark Licciardo
Company Secretary · since 2021
Paul Rickard
Non-Independent Non-Executive Director · since 2017
Non-Independent Non-Executive Director · since 2017
Stephen Merlicek
Non-Executive Independent Director · since 2017
Legal address
2 CHIFLEY SQUARE
SYDNEY, NSW 2000
AU
SYDNEY, NSW 2000
AU
Headquarters
'CHIFLEY TOWER' LEVEL 12 SUITE 12.04, CHIFLEY SQUARE
2 CHIFLEY SQUARE
SYDNEY, NSW 2000
AU
2 CHIFLEY SQUARE
SYDNEY, NSW 2000
AU
Previous name
CONTANGO GLOBAL GROWTH LIMITED
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||